State Aid Falls Short of $866,243 Jail MAT Cost in New York

A county jail is one of the few places where someone in opioid withdrawal is guaranteed to be found by a medical system, so they should be able to access care. Whether jail medication-assisted treatment is actually available when they get there, though, increasingly depends on whether the county can afford to provide it.

St. Lawrence County, New York budgeted $866,243 for the state-mandated jail medication-assisted treatment program in 2026. But a review now shows that the money didn’t actually come through.

What the Numbers Show

The jail received $160,000 in state aid toward the jail medication-assisted treatment program and the county’s Opioid Treatment Program combined, according to reporting by North Country Now on August 19, 2026. The 2026 MAT budget included zero funding from jail grants for the sixth consecutive year. Opioid Treatment Program services are running at a $578,690 loss in the same budget.

Meanwhile, total appropriations for the jail in 2026 came to $10,385,224.72, an 11.39% increase over the 2025 adopted budget.

County legislators have argued for years that the programs function as unfunded mandates absorbed by local taxpayers. In 2023, then-Sheriff Brooks Bigwarfe said the MAT program alone would likely cost the county in excess of $800,000, at a point when roughly $100,000 had been received to offset it. Costs have continued to climb since, and county officials say state aid has not kept pace. Officials describe the issues raised in 2023 as persisting into 2026.

Why Medical Detox Matters in Custody

Opioid withdrawal in a correctional setting is a medical event, and how it is handled has direct consequences for survival.

Withdrawal itself is rarely fatal in an otherwise healthy adult, though it can become dangerous through dehydration and electrolyte loss from sustained vomiting and diarrhea. The larger danger comes afterward. Forced abstinence during incarceration drives tolerance down sharply. When someone returns to their previous dose after release, the risk of fatal overdose is at its highest point.

This is the clinical reasoning behind mandating jail medication-assisted treatment during incarceration. Continuing or starting buprenorphine or methadone in jail keeps tolerance stable, treats withdrawal, and links people to community treatment on release rather than dropping them at the gate with neither.

Alcohol and benzodiazepine withdrawal carry a separate and more severe risk profile in the same setting, with seizures and delirium tremens both possible. Neither should be managed without medical supervision, in custody or anywhere else.

Understanding the Medications for Jail Medication-Assisted Treatment

Medication-assisted treatment or MAT pairs FDA approved medications with counseling and behavioral support. The FDA has approved three medications for opioid withdrawal and addiction recovery.

Methadone is a full opioid agonist. It occupies opioid receptors, preventing withdrawal and reducing cravings, and is dispensed through licensed opioid treatment programs under federal regulation. Because it is a full agonist, dosing requires careful supervision, particularly during induction.

Buprenorphine is a partial agonist with a ceiling effect that limits respiratory depression, which gives it a wider safety margin. It is available in several formulations, including daily sublingual tablets and films and extended-release monthly injections. The injectable form has been especially attractive in correctional settings because it removes the need for daily dosing and reduces the risk of diversion.

Naltrexone is an opioid antagonist. It blocks opioid effects rather than replacing them, and it causes no physical dependence. It must be started only after full detoxification, since giving it too early will accelerate withdrawal. That sequencing requirement is why naltrexone cannot substitute for withdrawal management.

All three reduce overdose mortality. They are not interchangeable, and the right one depends on the person, their history and their circumstances.

What This Means for Access

New York requires county jails to provide medication-assisted treatment. The mandate does not fund itself, though, and when the gap between requirement and reimbursement widens, counties cover it, trim it, or lean on opioid settlement dollars that were intended to expand services rather than backfill mandates.

For someone entering a county jail in opioid withdrawal, that budget line is not abstract. It determines whether a physician evaluates them, whether medication is started or continued, and whether anything is arranged for the day they walk out.

Finding Medical Detox in New York

If you or someone you love needs withdrawal management, do not wait on a system contact to make it happen. A clinical assessment determines what level of care fits, and that assessment should come before enrolling anywhere.

When contacting a detox center, ask what level of withdrawal management the facility provides, whether a physician evaluates you at intake, whether medication-assisted treatment is offered, and what the plan is for the period after detox ends. Detox alone has poor durability without something arranged to follow it.

Never attempt alcohol or benzodiazepine detox without medical supervision.

SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential and available 24 hours a day, and can refer you to treatment programs regardless of insurance status.

Detox.com lists medically supervised detox programs and opioid treatment programs by location, including throughout New York, with details on levels of care, medications offered and insurance accepted.